← Scoopfeeds — Intelligent news, curated.
AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push
business

AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push

Investing.com · Jun 22, 2026, 11:31 AM · Also reported by 4 other sources

AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion Bloomberg Markets AbbVie to Buy Apogee Therapeutics for $10.9 Billion Yahoo Finance Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics Yahoo Finance AbbVie acquires Apogee Therapeutics for $10.9 billion

More in business

Bloomberg Markets
A Blockbuster Summer for Debt Issuance
CoinDesk
Crypto's second U.S. lobbying front — tax policy — sees industry push on mining, staking
Bloomberg Markets
Chinese Carmakers Weighing Canada Manufacturing Deals, Joly Says
Yahoo Finance
AI Momentum Outweighs Iran Risks and Fed Concerns, Says Chief Economist
Forbes
What We Know About The Future Of Amazon’s Dropped Sam Altman Film Biopic
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop